Publications by authors named "Elle Pope"

8Publications

Little Consistency In Evidence Cited By Commercial Plans For Specialty Drug Coverage.

Health Aff (Millwood) 2019 11;38(11):1882-1886

Peter J. Neumann is director of the Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, and a professor of medicine in the School of Medicine, Tufts University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2019.00201DOI Listing
November 2019

Discrepancies Between FDA-Required Labeling and Evidence that Payers Cite in Drug Coverage Policies.

J Manag Care Spec Pharm 2018 Dec;24(12):1240-1246

1 The Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
https://www.jmcp.org/doi/10.18553/jmcp.2018.24.12.1240
Publisher Site
http://dx.doi.org/10.18553/jmcp.2018.24.12.1240DOI Listing
December 2018

Comorbidity Type and Health Care Costs in Type 2 Diabetes: A Retrospective Claims Database Analysis.

Diabetes Ther 2018 Oct 10;9(5):1907-1918. Epub 2018 Aug 10.

Real World Evidence and Clinical Outcomes, Sanofi, Bridgewater, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13300-018-0477-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167298PMC
October 2018

Specialty Drug Coverage Varies Across Commercial Health Plans In The US.

Health Aff (Millwood) 2018 07;37(7):1041-1047

Peter J. Neumann is director of the Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, and a professor of medicine in the School of Medicine, Tufts University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2017.1553DOI Listing
July 2018

A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical Procedures.

Value Health 2018 04 6;21(4):400-406. Epub 2017 Dec 6.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2017.10.007DOI Listing
April 2018

Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures.

Gates Open Res 2018 5;2. Epub 2018 Mar 5.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/gatesopenres.12786.2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801595PMC
March 2018

The influence of time horizon on results of cost-effectiveness analyses.

Expert Rev Pharmacoecon Outcomes Res 2017 Dec 23;17(6):615-623. Epub 2017 May 23.

a Center for the Evaluation of Value and Risk in Health , Institute for Clinical Research and Health Policy Studies, Tufts Medical Center , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737167.2017.1331432DOI Listing
December 2017